Absence of bacterially induced RELMβ reduces injury in the dextran sodium sulfate model of colitis

Laila D. McVay, Sue A. Keilbaugh, Tracie M.H. Wong, Sonja Kierstein, Marcus E. Shin, Michael Lehrke, Martina I. Lefterova, D. Edward Shifflett, Sean L. Barnes, Fabio Cominelli, Steven Cohn, Gail Hecht, Mitchell A. Lazar, Angela Haczku, Gary D. Wu

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Although inflammatory bowel disease (IBD) is the result of a dysregulated immune response to commensal gut bacteria in genetically predisposed individuals, the mechanism(s) by which bacteria lead to the development of IBD are unknown. Interestingly, deletion of intestinal goblet cells protects against intestinal injury, suggesting that this epithelial cell lineage may produce molecules that exacerbate IBD. We previously reported that resistin-like molecule β (RELMβ; also known as FIZZ2) is an intestinal goblet cell-specific protein that is induced upon bacterial colonization whereupon it is expressed in the ileum and colon, regions of the gut most often involved in IBD. Herein, we show that disruption of this gene reduces the severity of colitis in the dextran sodium sulfate (DSS) model of murine colonic injury. Although RELMβ does not alter colonic epithelial proliferation or barrier function, we show that recombinant protein activates macrophages to produce TNF-α both in vitro and in vivo. RELMβ expression is also strongly induced in the terminal ileum of the SAMP1/Fc model of IBD. These results suggest a model whereby the loss of epithelial barrier function by DSS results in the activation of the innate mucosal response by RELMβ located in the lumen, supporting the hypothesis that this protein is a link among goblet cells, commensal bacteria, and the pathogenesis of IBD.

Original languageEnglish (US)
Pages (from-to)2914-2923
Number of pages10
JournalJournal of Clinical Investigation
Volume116
Issue number11
DOIs
StatePublished - Nov 1 2006
Externally publishedYes

Fingerprint

Dextran Sulfate
Colitis
Inflammatory Bowel Diseases
Goblet Cells
Wounds and Injuries
Bacteria
Ileum
Resistin
Cell Lineage
Recombinant Proteins
Colon
Proteins
Epithelial Cells
Macrophages
Genes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

McVay, L. D., Keilbaugh, S. A., Wong, T. M. H., Kierstein, S., Shin, M. E., Lehrke, M., ... Wu, G. D. (2006). Absence of bacterially induced RELMβ reduces injury in the dextran sodium sulfate model of colitis. Journal of Clinical Investigation, 116(11), 2914-2923. https://doi.org/10.1172/JCI28121

Absence of bacterially induced RELMβ reduces injury in the dextran sodium sulfate model of colitis. / McVay, Laila D.; Keilbaugh, Sue A.; Wong, Tracie M.H.; Kierstein, Sonja; Shin, Marcus E.; Lehrke, Michael; Lefterova, Martina I.; Shifflett, D. Edward; Barnes, Sean L.; Cominelli, Fabio; Cohn, Steven; Hecht, Gail; Lazar, Mitchell A.; Haczku, Angela; Wu, Gary D.

In: Journal of Clinical Investigation, Vol. 116, No. 11, 01.11.2006, p. 2914-2923.

Research output: Contribution to journalArticle

McVay, LD, Keilbaugh, SA, Wong, TMH, Kierstein, S, Shin, ME, Lehrke, M, Lefterova, MI, Shifflett, DE, Barnes, SL, Cominelli, F, Cohn, S, Hecht, G, Lazar, MA, Haczku, A & Wu, GD 2006, 'Absence of bacterially induced RELMβ reduces injury in the dextran sodium sulfate model of colitis', Journal of Clinical Investigation, vol. 116, no. 11, pp. 2914-2923. https://doi.org/10.1172/JCI28121
McVay, Laila D. ; Keilbaugh, Sue A. ; Wong, Tracie M.H. ; Kierstein, Sonja ; Shin, Marcus E. ; Lehrke, Michael ; Lefterova, Martina I. ; Shifflett, D. Edward ; Barnes, Sean L. ; Cominelli, Fabio ; Cohn, Steven ; Hecht, Gail ; Lazar, Mitchell A. ; Haczku, Angela ; Wu, Gary D. / Absence of bacterially induced RELMβ reduces injury in the dextran sodium sulfate model of colitis. In: Journal of Clinical Investigation. 2006 ; Vol. 116, No. 11. pp. 2914-2923.
@article{34f947906f4c4676932bf9f5bcb73e19,
title = "Absence of bacterially induced RELMβ reduces injury in the dextran sodium sulfate model of colitis",
abstract = "Although inflammatory bowel disease (IBD) is the result of a dysregulated immune response to commensal gut bacteria in genetically predisposed individuals, the mechanism(s) by which bacteria lead to the development of IBD are unknown. Interestingly, deletion of intestinal goblet cells protects against intestinal injury, suggesting that this epithelial cell lineage may produce molecules that exacerbate IBD. We previously reported that resistin-like molecule β (RELMβ; also known as FIZZ2) is an intestinal goblet cell-specific protein that is induced upon bacterial colonization whereupon it is expressed in the ileum and colon, regions of the gut most often involved in IBD. Herein, we show that disruption of this gene reduces the severity of colitis in the dextran sodium sulfate (DSS) model of murine colonic injury. Although RELMβ does not alter colonic epithelial proliferation or barrier function, we show that recombinant protein activates macrophages to produce TNF-α both in vitro and in vivo. RELMβ expression is also strongly induced in the terminal ileum of the SAMP1/Fc model of IBD. These results suggest a model whereby the loss of epithelial barrier function by DSS results in the activation of the innate mucosal response by RELMβ located in the lumen, supporting the hypothesis that this protein is a link among goblet cells, commensal bacteria, and the pathogenesis of IBD.",
author = "McVay, {Laila D.} and Keilbaugh, {Sue A.} and Wong, {Tracie M.H.} and Sonja Kierstein and Shin, {Marcus E.} and Michael Lehrke and Lefterova, {Martina I.} and Shifflett, {D. Edward} and Barnes, {Sean L.} and Fabio Cominelli and Steven Cohn and Gail Hecht and Lazar, {Mitchell A.} and Angela Haczku and Wu, {Gary D.}",
year = "2006",
month = "11",
day = "1",
doi = "10.1172/JCI28121",
language = "English (US)",
volume = "116",
pages = "2914--2923",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "11",

}

TY - JOUR

T1 - Absence of bacterially induced RELMβ reduces injury in the dextran sodium sulfate model of colitis

AU - McVay, Laila D.

AU - Keilbaugh, Sue A.

AU - Wong, Tracie M.H.

AU - Kierstein, Sonja

AU - Shin, Marcus E.

AU - Lehrke, Michael

AU - Lefterova, Martina I.

AU - Shifflett, D. Edward

AU - Barnes, Sean L.

AU - Cominelli, Fabio

AU - Cohn, Steven

AU - Hecht, Gail

AU - Lazar, Mitchell A.

AU - Haczku, Angela

AU - Wu, Gary D.

PY - 2006/11/1

Y1 - 2006/11/1

N2 - Although inflammatory bowel disease (IBD) is the result of a dysregulated immune response to commensal gut bacteria in genetically predisposed individuals, the mechanism(s) by which bacteria lead to the development of IBD are unknown. Interestingly, deletion of intestinal goblet cells protects against intestinal injury, suggesting that this epithelial cell lineage may produce molecules that exacerbate IBD. We previously reported that resistin-like molecule β (RELMβ; also known as FIZZ2) is an intestinal goblet cell-specific protein that is induced upon bacterial colonization whereupon it is expressed in the ileum and colon, regions of the gut most often involved in IBD. Herein, we show that disruption of this gene reduces the severity of colitis in the dextran sodium sulfate (DSS) model of murine colonic injury. Although RELMβ does not alter colonic epithelial proliferation or barrier function, we show that recombinant protein activates macrophages to produce TNF-α both in vitro and in vivo. RELMβ expression is also strongly induced in the terminal ileum of the SAMP1/Fc model of IBD. These results suggest a model whereby the loss of epithelial barrier function by DSS results in the activation of the innate mucosal response by RELMβ located in the lumen, supporting the hypothesis that this protein is a link among goblet cells, commensal bacteria, and the pathogenesis of IBD.

AB - Although inflammatory bowel disease (IBD) is the result of a dysregulated immune response to commensal gut bacteria in genetically predisposed individuals, the mechanism(s) by which bacteria lead to the development of IBD are unknown. Interestingly, deletion of intestinal goblet cells protects against intestinal injury, suggesting that this epithelial cell lineage may produce molecules that exacerbate IBD. We previously reported that resistin-like molecule β (RELMβ; also known as FIZZ2) is an intestinal goblet cell-specific protein that is induced upon bacterial colonization whereupon it is expressed in the ileum and colon, regions of the gut most often involved in IBD. Herein, we show that disruption of this gene reduces the severity of colitis in the dextran sodium sulfate (DSS) model of murine colonic injury. Although RELMβ does not alter colonic epithelial proliferation or barrier function, we show that recombinant protein activates macrophages to produce TNF-α both in vitro and in vivo. RELMβ expression is also strongly induced in the terminal ileum of the SAMP1/Fc model of IBD. These results suggest a model whereby the loss of epithelial barrier function by DSS results in the activation of the innate mucosal response by RELMβ located in the lumen, supporting the hypothesis that this protein is a link among goblet cells, commensal bacteria, and the pathogenesis of IBD.

UR - http://www.scopus.com/inward/record.url?scp=33750585364&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750585364&partnerID=8YFLogxK

U2 - 10.1172/JCI28121

DO - 10.1172/JCI28121

M3 - Article

VL - 116

SP - 2914

EP - 2923

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 11

ER -